Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,710 public trials 619 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Active, Not Recruiting

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT05769777

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • Allervie Clinical Research - Birmingham- Site Number : 8400050 Birmingham, Alabama, United States
  • Research Solutions of Arizona- Site Number : 8400020 Litchfield Park, Arizona, United States
  • Dermatology Trial Associates- Site Number : 8400027 Bryant, Arkansas, United States
  • University Dermatology Trials- Site Number : 8400052 Newport Beach, California, United States
View all 174 locations
View Trial Details
Active, Not Recruiting

A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

NCT06526182

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Hospital General Universitario Dr. Balmis Alicante, Spain
  • Hospital del Mar - Parc de Salut Mar Barcelona, Spain
  • Hospital Universitario Clínico San Cecilio Granada, Spain
  • Consorci Hospital General Universitari de València Valencia, Spain
View Trial Details
Active, Not Recruiting

To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

NCT06552520

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Tongling People's Hospital Tongling, Anhui, China
  • The Second Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
View all 73 locations
View Trial Details
Active, Not Recruiting

A Phase 2 in Adult Subjects With Hereditary Angioedema

NCT06846398

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Institute for Asthma and Allergy - Wheaton Silver Spring, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Duke University Medicine Center Durham, North Carolina, United States
  • Penn State Milton S. Hershey MC - Penn State Hershey, Pennsylvania, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma

NCT05097287

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Cullman Research Center- Site Number : 8400001 Cullman, Alabama, United States
  • Shoals Primary Care - Sheffield- Site Number : 8400015 Sheffield, Alabama, United States
  • Chandler Clinical Research Trials- Site Number : 8400147 Chandler, Arizona, United States
  • Pulmonary Associates - Deer Valley Office- Site Number : 8400155 Phoenix, Arizona, United States
View all 249 locations
View Trial Details
Active, Not Recruiting

A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis

NCT05983068

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations
  • National Jewish Health Medical Center- Site Number : 8400001 Denver, Colorado, United States
  • SSM Health Saint Louis University Hospital- Site Number : 8400006 St Louis, Missouri, United States
  • NYU Langone Medical Center- Site Number : 8400004 New York, United States
  • Investigational Site Number : 8260001 Sheffield, United Kingdom
View Trial Details

Related conditions